Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Invests in UK Startup Studying Metabolites

NEW YORK, June 14 – Gene Logic has invested in Metabometrix, a London-based startup studying metabolites in human fluids, and will partner with the company to link gene expression information with metabolite data, the companies said Thursday. 

The companies did not disclose the amount of the equity investment, or other financial details. 

Metabometrix uses NMR and flow-injection technology to study how metabolites--the break-down products of proteins involved in cellular pathways--change in response to disease or therapy. The company says its technology is useful for drug toxicity and efficacy screening, clinical diagnostics, and environmental science.

The research collaboration will focus initially on adding metabolite information to Gene Logic’s toxicology database, which the company hopes will allow pharmaceutical companies to rank potential therapeutics according to their toxicity. 

"We are pleased to make this initial investment in Metabometrix and anticipate identifying the relationship between genomic and metabonomic markers for human disease and toxicity," Mark Gessler, CEO of Gene Logic, said in a statement.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.